Androgen Receptor Splicing Variant-7 in Breast Cancer: Clinical and Pathologic Correlations

Androgen receptor (AR) inhibitor therapy is a developing treatment for AR-positive breast cancer (BC) with ongoing clinical trials. AR splicing variant-7 (AR-V7) is a truncated variant of AR that leads to AR inhibitor therapy resistance in prostate cancer; recent studies have identified AR-V7 in BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Donna C., Mata, Douglas A., Tay, Timothy KY., Traina, Tiffany A., Gucalp, Ayca, Chandarlapaty, Sarat, D’Alfonso, Timothy M., Brogi, Edi, Mullaney, Kerry, Ladanyi, Marc, Arcila, Maria E., Benayed, Ryma, Ross, Dara S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863633/
https://www.ncbi.nlm.nih.gov/pubmed/34593966
http://dx.doi.org/10.1038/s41379-021-00924-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863633/
https://www.ncbi.nlm.nih.gov/pubmed/34593966
http://dx.doi.org/10.1038/s41379-021-00924-5

Ejemplares similares